Published in Nat Biotechnol on April 10, 2012
Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature (2013) 6.57
An atlas of genetic influences on human blood metabolites. Nat Genet (2014) 3.21
The support of human genetic evidence for approved drug indications. Nat Genet (2015) 3.03
Beyond GWASs: illuminating the dark road from association to function. Am J Hum Genet (2013) 2.67
Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review. Pharmacol Ther (2013) 2.64
VisANT 4.0: Integrative network platform to connect genes, drugs, diseases and therapies. Nucleic Acids Res (2013) 1.71
Large-scale genomics unveils the genetic architecture of psychiatric disorders. Nat Neurosci (2014) 1.64
Transcriptional data: a new gateway to drug repositioning? Drug Discov Today (2012) 1.40
Objective assessment of cancer genes for drug discovery. Nat Rev Drug Discov (2013) 1.34
Rational drug repositioning by medical genetics. Nat Biotechnol (2013) 1.26
Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality. J Am Med Inform Assoc (2014) 1.25
Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines. Drug Discov Today (2013) 1.24
A survey of current trends in computational drug repositioning. Brief Bioinform (2015) 1.18
Drug repositioning: a machine-learning approach through data integration. J Cheminform (2013) 1.11
TargetHunter: an in silico target identification tool for predicting therapeutic potential of small organic molecules based on chemogenomic database. AAPS J (2013) 1.11
Gene-expression data integration to squamous cell lung cancer subtypes reveals drug sensitivity. Br J Cancer (2013) 1.09
Bayesian analysis of genetic association across tree-structured routine healthcare data in the UK Biobank. Nat Genet (2017) 1.07
DiseaseConnect: a comprehensive web server for mechanism-based disease-disease connections. Nucleic Acids Res (2014) 0.99
A weighted and integrated drug-target interactome: drug repurposing for schizophrenia as a use case. BMC Syst Biol (2015) 0.99
Genetic architecture of colorectal cancer. Gut (2015) 0.97
Genomic modulators of the immune response. Trends Genet (2012) 0.94
Drug Promiscuity in PDB: Protein Binding Site Similarity Is Key. PLoS One (2013) 0.94
Human genetics in rheumatoid arthritis guides a high-throughput drug screen of the CD40 signaling pathway. PLoS Genet (2013) 0.93
GWAS and drug targets. BMC Genomics (2014) 0.93
Mouse model phenotypes provide information about human drug targets. Bioinformatics (2013) 0.93
Metabolomics enables precision medicine: "A White Paper, Community Perspective". Metabolomics (2016) 0.93
Targeting the schizophrenia genome: a fast track strategy from GWAS to clinic. Mol Psychiatry (2015) 0.93
Identification of novel therapeutics for complex diseases from genome-wide association data. BMC Med Genomics (2014) 0.90
Computational systems biology approaches to anti-angiogenic cancer therapeutics. Drug Discov Today (2014) 0.90
Towards drug repositioning: a unified computational framework for integrating multiple aspects of drug similarity and disease similarity. AMIA Annu Symp Proc (2014) 0.89
Compensating for literature annotation bias when predicting novel drug-disease relationships through Medical Subject Heading Over-representation Profile (MeSHOP) similarity. BMC Med Genomics (2013) 0.89
Recent genetic findings in schizophrenia and their therapeutic relevance. J Psychopharmacol (2014) 0.88
TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traits. PLoS One (2015) 0.88
Approaches for establishing the function of regulatory genetic variants involved in disease. Genome Med (2014) 0.87
Allelic expression mapping across cellular lineages to establish impact of non-coding SNPs. Mol Syst Biol (2014) 0.86
Towards precision medicine-based therapies for glioblastoma: interrogating human disease genomics and mouse phenotypes. BMC Genomics (2016) 0.85
Predicting disease associations via biological network analysis. BMC Bioinformatics (2014) 0.85
Combining Human Disease Genetics and Mouse Model Phenotypes towards Drug Repositioning for Parkinson's disease. AMIA Annu Symp Proc (2015) 0.84
Construction of drug network based on side effects and its application for drug repositioning. PLoS One (2014) 0.84
Use of genome-wide association studies for cancer research and drug repositioning. PLoS One (2015) 0.84
Meta-Analyses of Genome-Wide Association Data Hold New Promise for Addiction Genetics. J Stud Alcohol Drugs (2016) 0.83
Translating genome-wide association findings into new therapeutics for psychiatry. Nat Neurosci (2016) 0.83
Genetics, ancestry, and hypertension: implications for targeted antihypertensive therapies. Curr Hypertens Rep (2014) 0.83
Drug repositioning for diabetes based on 'omics' data mining. PLoS One (2015) 0.83
Surveying Recent Themes in Translational Bioinformatics: Big Data in EHRs, Omics for Drugs, and Personal Genomics. Yearb Med Inform (2014) 0.83
Phenome-Wide Association Studies as a Tool to Advance Precision Medicine. Annu Rev Genomics Hum Genet (2016) 0.83
'RE:fine drugs': an interactive dashboard to access drug repurposing opportunities. Database (Oxford) (2016) 0.82
A genomics-based systems approach towards drug repositioning for rheumatoid arthritis. BMC Genomics (2016) 0.82
Progress and future aspects in genetics of human hypertension. Curr Hypertens Rep (2013) 0.82
The future for genetic studies in reproduction. Mol Hum Reprod (2013) 0.81
A network perspective on unraveling the role of TRP channels in biology and disease. Pflugers Arch (2013) 0.81
An Integrated Data Driven Approach to Drug Repositioning Using Gene-Disease Associations. PLoS One (2016) 0.81
Open Targets: a platform for therapeutic target identification and validation. Nucleic Acids Res (2016) 0.81
Mining integrated semantic networks for drug repositioning opportunities. PeerJ (2016) 0.80
A comparative study of disease genes and drug targets in the human protein interactome. BMC Bioinformatics (2015) 0.80
Precision medicine informatics. J Am Med Inform Assoc (2016) 0.79
Human genome-guided identification of memory-modulating drugs. Proc Natl Acad Sci U S A (2013) 0.78
Leveraging human genetics to guide drug target discovery. Trends Cardiovasc Med (2016) 0.78
Reply to Rational drug repositioning by medical genetics. Nat Biotechnol (2013) 0.78
Identifying prognostic features by bottom-up approach and correlating to drug repositioning. PLoS One (2015) 0.77
Phenome-based gene discovery provides information about Parkinson's disease drug targets. BMC Genomics (2016) 0.77
Using VisANT to Analyze Networks. Curr Protoc Bioinformatics (2014) 0.77
Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets. Nat Genet (2017) 0.77
Drug repositioning for orphan genetic diseases through Conserved Anticoexpressed Gene Clusters (CAGCs). BMC Bioinformatics (2013) 0.77
The case for genome-wide association studies of bone acquisition in paediatric and adolescent populations. Bonekey Rep (2016) 0.76
Drug repositioning approaches for the discovery of new therapeutics for Alzheimer's disease. Neurotherapeutics (2015) 0.76
Genetic Discoveries in Atrial Fibrillation and Implications for Clinical Practice. Arrhythm Electrophysiol Rev (2014) 0.76
Explore Small Molecule-induced Genome-wide Transcriptional Profiles for Novel Inflammatory Bowel Disease Drug. AMIA Jt Summits Transl Sci Proc (2016) 0.75
Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining. PLoS One (2016) 0.75
Using Social Media Data to Identify Potential Candidates for Drug Repurposing: A Feasibility Study. JMIR Res Protoc (2016) 0.75
Pathway and network-based strategies to translate genetic discoveries into effective therapies. Hum Mol Genet (2016) 0.75
Human genetics as a model for target validation: finding new therapies for diabetes. Diabetologia (2017) 0.75
Repurposing paclitaxel for the treatment of fibrosis: indication discovery for existing drugs. Drug Des Devel Ther (2015) 0.75
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System. J Vis Exp (2016) 0.75
An integrated structure- and system-based framework to identify new targets of metabolites and known drugs. Bioinformatics (2015) 0.75
Systematic integration of biomedical knowledge prioritizes drugs for repurposing. Elife (2017) 0.75
Drug enrichment and discovery from schizophrenia genome-wide association results: an analysis and visualisation approach. Sci Rep (2017) 0.75
Schizophrenia genetics comes to translation. NPJ Schizophr (2017) 0.75
Analysis of genome-wide association data highlights candidates for drug repositioning in psychiatry. Nat Neurosci (2017) 0.75
Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science (2007) 32.97
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet (2008) 30.20
Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet (2008) 20.73
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet (2010) 17.38
Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet (2009) 9.45
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet (2011) 7.98
Multiple common variants for celiac disease influencing immune gene expression. Nat Genet (2010) 6.90
Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat Genet (2010) 6.68
Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet (2009) 3.82
New sequence variants associated with bone mineral density. Nat Genet (2008) 3.43
E2-2 protein and Fuchs's corneal dystrophy. N Engl J Med (2010) 3.31
Genome-wide association analysis identifies three psoriasis susceptibility loci. Nat Genet (2010) 2.76
Essential tremor. Lancet Neurol (2005) 2.64
Variant in the sequence of the LINGO1 gene confers risk of essential tremor. Nat Genet (2009) 2.29
The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss. Gut (2005) 1.91
Replication of the LINGO1 gene association with essential tremor in a North American population. Eur J Hum Genet (2010) 1.32
Unraveling the directional link between adiposity and inflammation: a bidirectional Mendelian randomization approach. J Clin Endocrinol Metab (2009) 1.27
Detection of nitric oxide and nitric oxide synthases in psoriasis. Arch Dermatol Res (1998) 1.25
Database identifies FDA-approved drugs with potential to be repurposed for treatment of orphan diseases. Brief Bioinform (2011) 1.17
Treatment of psoriasis with topical NG-monomethyl-L-arginine, an inhibitor of nitric oxide synthesis. Br J Dermatol (2000) 0.88
Initial sequencing and comparative analysis of the mouse genome. Nature (2002) 96.15
A second generation human haplotype map of over 3.1 million SNPs. Nature (2007) 85.39
Finding the missing heritability of complex diseases. Nature (2009) 67.95
Merlin--rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet (2001) 53.16
A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science (2007) 37.88
Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science (2007) 32.97
Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet (2008) 30.94
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet (2008) 30.20
Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21
Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet (2008) 22.35
Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
Genome-wide detection and characterization of positive selection in human populations. Nature (2007) 17.27
Genome-wide association analysis identifies 20 loci that influence adult height. Nat Genet (2008) 16.92
Replicating genotype-phenotype associations. Nature (2007) 16.11
Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet (2008) 15.94
The effects of human population structure on large genetic association studies. Nat Genet (2004) 14.88
Genome-wide strategies for detecting multiple loci that influence complex diseases. Nat Genet (2005) 14.88
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet (2007) 12.62
Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44
Prepublication data sharing. Nature (2009) 12.24
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet (2009) 12.19
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet (2012) 12.10
Evaluating coverage of genome-wide association studies. Nat Genet (2006) 11.40
Variants in MTNR1B influence fasting glucose levels. Nat Genet (2008) 10.85
Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 8.89
Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet (2010) 8.55
A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet (2007) 8.50
Thousands of chemical starting points for antimalarial lead identification. Nature (2010) 8.28
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people. Science (2012) 7.94
Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet (2012) 7.59
A first-generation linkage disequilibrium map of human chromosome 22. Nature (2002) 7.03
Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66
LDL-cholesterol concentrations: a genome-wide association study. Lancet (2008) 6.44
A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry (2012) 6.34
A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet (2009) 6.31
Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet (2009) 5.81
Two-stage two-locus models in genome-wide association. PLoS Genet (2006) 5.60
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48
The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord (2008) 5.33
Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet (2009) 5.32
Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA (2009) 5.32
The complex interplay among factors that influence allelic association. Nat Rev Genet (2004) 5.26
Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol (2007) 5.09
Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet (2009) 4.97
The Population Reference Sample, POPRES: a resource for population, disease, and pharmacological genetics research. Am J Hum Genet (2008) 4.79
Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet (2008) 4.78
Global patterns of cis variation in human cells revealed by high-density allelic expression analysis. Nat Genet (2009) 4.72
Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am J Hum Genet (2008) 4.69
Linkage disequilibrium mapping via cladistic analysis of single-nucleotide polymorphism haplotypes. Am J Hum Genet (2004) 4.44
A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet (2012) 4.37
Evaluating the effects of imputation on the power, coverage, and cost efficiency of genome-wide SNP platforms. Am J Hum Genet (2008) 4.28
Meta-analysis of genome-wide scans for human adult stature identifies novel Loci and associations with measures of skeletal frame size. PLoS Genet (2009) 4.24
Comparative gene prediction in human and mouse. Genome Res (2003) 4.13
Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol (2010) 4.08
Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet (2009) 3.92
The UK10K project identifies rare variants in health and disease. Nature (2015) 3.89
Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet (2009) 3.82
Genetic loci influencing kidney function and chronic kidney disease. Nat Genet (2010) 3.75
Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Natl Acad Sci U S A (2004) 3.73
Comparison of mouse and human genomes followed by experimental verification yields an estimated 1,019 additional genes. Proc Natl Acad Sci U S A (2003) 3.73
Data quality control in genetic case-control association studies. Nat Protoc (2010) 3.68
The association between physical activity in leisure time and leukocyte telomere length. Arch Intern Med (2008) 3.68
Measures of human population structure show heterogeneity among genomic regions. Genome Res (2005) 3.68
Investigation of the fine structure of European populations with applications to disease association studies. Eur J Hum Genet (2008) 3.65
Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet (2011) 3.40
Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet (2010) 3.37
Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet (2013) 3.25
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21
Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet (2011) 3.18
Targeted screening of cis-regulatory variation in human haplotypes. Genome Res (2008) 3.10
Genetic variation in LIN28B is associated with the timing of puberty. Nat Genet (2009) 3.09
The empirical power of rare variant association methods: results from sanger sequencing in 1,998 individuals. PLoS Genet (2012) 2.86
A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. Am J Hum Genet (2005) 2.85
The impact of SNP density on fine-scale patterns of linkage disequilibrium. Hum Mol Genet (2004) 2.78
Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet (2011) 2.73
Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA (2008) 2.73
Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med (2013) 2.73
CUBN is a gene locus for albuminuria. J Am Soc Nephrol (2011) 2.70
Survey of allelic expression using EST mining. Genome Res (2005) 2.67
An evaluation of HapMap sample size and tagging SNP performance in large-scale empirical and simulated data sets. Nat Genet (2005) 2.66
Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi. Nat Genet (2009) 2.65
Human disease-drug network based on genomic expression profiles. PLoS One (2009) 2.62
GOLDsurfer: three dimensional display of linkage disequilibrium. Bioinformatics (2004) 2.61
Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus. Nature (2011) 2.59
Efficient selective screening of haplotype tag SNPs. Bioinformatics (2003) 2.57
Association of JAG1 with bone mineral density and osteoporotic fractures: a genome-wide association study and follow-up replication studies. Am J Hum Genet (2010) 2.57
Allele-specific chromatin remodeling in the ZPBP2/GSDMB/ORMDL3 locus associated with the risk of asthma and autoimmune disease. Am J Hum Genet (2009) 2.56
A probabilistic approach for SNP discovery in high-throughput human resequencing data. Genome Res (2009) 2.55
An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metab (2011) 2.52
The impact of genotyping error on haplotype reconstruction and frequency estimation. Eur J Hum Genet (2002) 2.51
Independent genome-wide scans identify a chromosome 18 quantitative-trait locus influencing dyslexia. Nat Genet (2001) 2.48